Table I.
Demographics and Baseline Clinical Characteristics by Treatment Group
| Characteristic | SCJ (N = 20) | SC (N = 19) | Total sample (N = 39) |
|---|---|---|---|
| Child age, M (SD) | 8.4 (1.4) | 7.6 (1.5) | 8.0 (1.5) |
| Parent age, M (SD) | 34.7 (12.7) | 32.7 (12.2) | 33.7 (12.3) |
| Duration of diabetes, M (SD) | 3.0 (1.5) | 3.7 (1.8) | 3.4 (1.7) |
| A1C (%), M (SD) | 8.6 (1.6) | 8.5 (1.5) | 8.6 (1.5) |
| Sex | |||
| Male (%) | 8 (40%) | 6 (32%) | 14 (36%) |
| Female (%) | 12 (60%) | 13 (68%) | 25 (64%) |
| Race/ethnicity | |||
| White, non-Hispanic, N (%) | 15 (75%) | 14 (74%) | 29 (74%) |
| Non-white, N (%) | 4 (20%) | 4 (21%) | 8 (20%) |
| White, Hispanic, N (%) | 1 (5%) | 0 (0%) | 1 (3%) |
| Not reported, N (%) | 0 (0%) | 1 (5%) | 1 (3%) |
| Annual income (USD) | |||
| <39,000, N (%) | 2 (10%) | 5 (26%) | 7 (18%) |
| 40,000–79,000, N (%) | 7 (35%) | 6 (32%) | 13 (33%) |
| >80,000, N (%) | 11 (55%) | 8 (42%) | 19 (49%) |
| Treatment type | |||
| Insulin pump, N (%) | 12 (60%) | 12 (63%) | 24 (62%) |
| Injections, N (%) | 8 (40%) | 7 (37%) | 15 (38%) |
| CGM use, N (%) | 14 (70%) | 10 (53%) | 24 (62%) |
Note. SCJ = Sleep Coach Jr. intervention; SC = standard care; CGM = continuous glucose monitor.